{"id":"W3033065537","doi":"10.1016/j.bone.2020.115472","title":"Bone morphogenetic protein receptors: Structure, function and targeting by selective small molecule kinase inhibitors","year":2020,"lang":"en","type":"review","venue":"Bone","topic":"Heterotopic Ossification and Related Conditions","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Eshelman Institute for Innovation, University of North Carolina at Chapel Hill; Janssen Pharmaceuticals; European Research Council; AFM-Téléthon; French Muscular Dystrophy Association; Wellcome Trust; Innovative Medicines Initiative; Hartstichting; Meso Scale Diagnostics; Cancer Genomics Centre; ZonMw; Boehringer Ingelheim; Takeda Pharmaceutical Company; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; Nederlandse Federatie van Universitair Medische Centra; Ontario Genomics; Fundação de Amparo à Pesquisa do Estado de São Paulo; Genome Canada; Novartis Pharma; Canada Foundation for Innovation; Ontario Genomics Institute; Novartis; Vetenskapsrådet; Pfizer","keywords":"BMPR2; Bone morphogenetic protein receptor; Bone morphogenetic protein; Cell biology; Signal transduction; Kinase; SMAD; Receptor; Phosphorylation; Activin receptor; Biology; Endoglin; Cell signaling; Cancer research; Chemistry; Biochemistry; Gene","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001870445,0.0005493297,0.0003067793,0.0003449651,0.0001119586,0.0003494199,0.0003070494,0.000314957,0.001225842],"category_scores_gemma":[0.00007605764,0.0001502731,0.0002275505,0.0002144352,0.0001802333,0.0002407803,0.0002039902,0.0005379641,0.001073214],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000439222,"about_ca_system_score_gemma":0.0001912232,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003500216,"about_ca_topic_score_gemma":0.0008298332,"domain_scores_codex":[0.9999205,0.00001039664,0.000004199792,0.00001394291,0.000028942,0.00002205326],"domain_scores_gemma":[0.9999818,0.000002518068,0.000005497046,0.000001295503,0.000003428929,0.000005427576],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005657939,0.0002276548,0.0003375407,0.0007571835,0.00003743814,0.0003515944,0.0000383917,0.001238096,0.7712501,0.006892263,0.006654807,0.2116492],"study_design_scores_gemma":[0.000347862,0.001110853,0.00277503,0.0000738907,0.0001202819,0.003703373,0.000027489,0.003568318,0.6616122,0.001178674,0.3254412,0.00004082158],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.2794034,0.6316153,0.03719698,0.004070562,0.0008715395,0.0005625633,0.001860895,0.001340079,0.04307865],"genre_scores_gemma":[0.5742065,0.3687005,0.018064,0.001103696,0.0003737742,0.0004898946,0.002052811,0.0001271055,0.03488173],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.001225842,"threshold_uncertainty_score":0.0041008,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0181909919407304,"score_gpt":0.2610062897518836,"score_spread":0.2428152978111532,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}